Increasing investment in automotive electronics, DBG Technology plans to acquire symbol Assets of 0.733 billion yuan from Aerospace Hi-Tech Holding Group | Quick Announcement

① DBG Technology plans to acquire 100% equity of AC Company for 0.733 billion yuan and 0.003% equity of TIS Company; ② The equity of the restructured symbol companies, including AC Company, is held by a subsidiary of Aerospace Hi-Tech Holding Group.

cls.cnMar 4 23:11

Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 3 10:09

Suspected of major financial fraud! Orient Group Incorporation is currently at risk of being (Delisted). How can the rights of 0.129 million Shareholders be protected?

① The China Securities Regulatory Commission reported that it has preliminarily determined that the financial information disclosed by Orient Group Incorporation from 2020 to 2023 is severely inaccurate, suspected of significant financial fraud, which may involve serious violations that lead to (Delisted); ② As of the end of the third quarter of 2024, Orient Group Incorporation still has 0.129 million Shareholders, raising concerns about how investors can protect their legal rights.

cls.cnMar 1 11:01

The final judgment resulted in a compensation exceeding 60 million yuan, Tonghua Dongbao Pharmaceutical revised its performance forecast | Interpretations

① The final judgment requires compensation to Gan & Lee Pharmaceuticals exceeding 60 million yuan, and Tonghua Dongbao Pharmaceutical adjusts its performance for 2024; ② The company's controlling shareholder Dongbao Group has pledged shares amounting to nearly 30% of the company's total equity.

cls.cnFeb 26 20:46

Express News | Hong Kong stock steel shares surged in the short term, CHINA ORIENTAL rose more than 30%, CHONGQING IRON rose more than 14%, Angang Steel rose more than 11%, and MAANSHAN IRON rose nearly 9%.

BreakingsFeb 26 11:54

Goldman Sachs launched the China AI Medical Index! These 8 Hong Kong stocks made the list, with the strongest one increasing over 69% this month.

Sinolink stated that the interest in AI-related Medical symbols continues to rise. With the emergence of AI in healthcare and rapid industry advancement, a significant change in Medical investment is expected by 2025. It is recommended to focus on the innovative growth track, with the two major growth Sectors of "AI + Medical" and Innovative Drugs being the most important battlegrounds for Medical investment in 2025.

Futu NewsFeb 21 13:42